Rest activity rhythms characteristics of breast cancer women following endocrine therapy
Tristan Martin(Le Mans Université), Joy Perrier(Inserm), Francis Eustache(Inserm), Nicolas Bessot(Inserm), Mylène Duivon(Inserm), Bénédicte Giffard(Inserm), Lucie Raoul(Inserm), Florence Joly(Inserm), George Emile(Centre François Baclesse), Fausto Viader(Inserm), Sébastien Polvent(Inserm), Jean‐Michel Grellard(Centre François Baclesse)
Cited by 10
Related Papers
BRAF Inhibition in <i>BRAF</i> <sup>V600</sup> -Mutant Gliomas: Results From the VE-BASKET Study
|Journal of Clinical Oncology|2018|330
An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32)
|European Journal of Cancer|2005|241
An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer
|Nature Medicine|2021|115
Cancer-related cognitive impairment: current perspectives on the management of cognitive changes following cancer treatment
|Expert Review of Neurotherapeutics|2023|31
Cancer-related cognitive impairment in non-CNS cancer patients: Targeted review and future action plans in Europe
|Critical Reviews in Oncology/Hematology|2022|29